Literature DB >> 25795746

Diagnostic error: what Muir-Torre syndrome has taught us.

Dmitri Wall1, Caitriona Bridget Hackett1, Vourneen Healy2, Bart Ramsay1.   

Abstract

A low-grade sebaceous carcinoma was excised from a 55-year-old woman's neck. At follow-up, 11 months later, a recent diagnosis of mucinous adenocarcinoma of the colon and history of clear cell endometrial carcinoma were identified. A strong family history of bowel cancer suggested Muir-Torre syndrome. Unexpectedly, hereditary non-polyposis colorectal cancer had previously been genetically confirmed; the results were found loosely filed in the paper chart. The patient had not informed us about her diagnosis; having discussed the case with other physicians she felt the diagnosis would be common knowledge. In 1999, US National Institute of Medicine estimated that preventable medical error resulted in the deaths of 44-98 000 people yearly in US hospitals. Four categories of medical error, including diagnosis, treatment, preventive and 'other' were described, while the reasoning processes that result in these errors are outlined by Reason et al. We utilise this rare case to illustrate these important concepts. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25795746      PMCID: PMC4368964          DOI: 10.1136/bcr-2014-206959

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Human error: models and management

Authors: 
Journal:  West J Med       Date:  2000-06

2.  A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome.

Authors:  E Mangold; C Pagenstecher; M Leister; M Mathiak; A Rütten; W Friedl; P Propping; T Ruzicka; R Kruse
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

3.  Error in medicine.

Authors:  L L Leape
Journal:  JAMA       Date:  1994-12-21       Impact factor: 56.272

4.  Clinical, dermoscopic and reflectance confocal microscopy features of sebaceous neoplasms in Muir-Torre syndrome.

Authors:  E Moscarella; G Argenziano; C Longo; C Cota; M Ardigò; V Stigliano; L S Mete; P Donati; S Piana; V Silipo; C Catricalà; G Albertini; I Zalaudek
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-04-04       Impact factor: 6.166

5.  Preventing medical injury.

Authors:  L L Leape; A G Lawthers; T A Brennan; W G Johnson
Journal:  QRB Qual Rev Bull       Date:  1993-05

6.  Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy.

Authors:  Megan N Landis; Carrie L Davis; Gary A Bellus; Stephen E Wolverton
Journal:  J Am Acad Dermatol       Date:  2011-05-06       Impact factor: 11.527

7.  The frequency of Muir-Torre syndrome among Lynch syndrome families.

Authors:  Christopher D South; Heather Hampel; Ilene Comeras; Judith A Westman; Wendy L Frankel; Albert de la Chapelle
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.